Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Magic bullet homes in

04.03.2002


The search for a magic bullet to kill only cancer cells has been on for years.
© Getty Images


New candidate cancer drug does damage only in tumours.

A new drug turns lethal only when it reaches cancer cells. In healthy cells it is harmless. Though not yet shown to work in humans, it is a step towards a magic bullet to knock out tumour cells selectively, with minimal side effects.

The drug works in mice implanted with human tumours, say chemists Lutz Tietze and colleagues at the University of Gottingen in Germany. Before being treated with the drug, the mice are given an enzyme to activate it that sticks only to the human tumour cells, ignoring healthy mouse cells. So the drug is safe until the enzyme activates it in the tumour. Then it destroys the cancerous cells1.



The researchers report that the tumours shrank without inducing any visible side effects in the mice. They think that the same principles could be used in people. The activating enzyme could be tailored to latch onto malignant tissues and bypass normal human cells.

"We are now in contact with the pharmaceutical industry, and will start clinical tests", says Tietze.

Magic bullet

Most existing chemotherapy is toxic to normal cells as well as cancerous ones. This causes severe side effects, such as a depressed immune system. Cancer researchers long for a magic bullet: a drug that works only where it is needed.

The warhead of the Gottingen antitumour molecule is a ring of three carbon atoms. This ring is highly strained and apt to burst open. Open, it is a reactive molecule that wreaks havoc among the nucleic acid molecules essential for normal cell function. The chemists copied this trick from a highly toxic antibiotic produced by a fungus.

So that their molecular bomb does not detonate everywhere in the body, the team have made a ’prodrug’. This is like the natural antibiotic but without the strained ring and with a sugar safety-catch. Once the sugar is clipped off, the molecule rearranges itself into a three-atom ring, and proceeds to do its toxic business.

Tietze’s team uses an enzyme to cut away the sugar safety-catch. An antibody on the enzyme acts as a tumour-specific hook. Such antibodies linked to toxic or radioactive molecules have long been explored for making magic-bullet drugs; none has yet found clinical use.

The advantage of this enzyme-activated approach, originally developed in the 1980s, is that the drug isn’t even activated until it reaches the target site. The selectivity of the damage still depends on antibody’s ability to hook onto the right cells, and on the absence of other enzymes in the body that also activate the prodrug.

Whether the idea will work cleanly enough in humans remains to be seen.

References

  1. Tietze, L. F. et al. Proof of principle in the selective treatment of cancer by antibody-directed enzyme prodrug therapy: the development of a highly potent prodrug. Angewandte Chemie International Edition, 41, 759 - 761, (2002).


PHILIP BALL | © Nature News Service

More articles from Health and Medicine:

nachricht Routing gene therapy directly into the brain
07.12.2017 | Boston Children's Hospital

nachricht New Hope for Cancer Therapies: Targeted Monitoring may help Improve Tumor Treatment
01.12.2017 | Berliner Institut für Gesundheitsforschung / Berlin Institute of Health (BIH)

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Scientists channel graphene to understand filtration and ion transport into cells

Tiny pores at a cell's entryway act as miniature bouncers, letting in some electrically charged atoms--ions--but blocking others. Operating as exquisitely sensitive filters, these "ion channels" play a critical role in biological functions such as muscle contraction and the firing of brain cells.

To rapidly transport the right ions through the cell membrane, the tiny channels rely on a complex interplay between the ions and surrounding molecules,...

Im Focus: Towards data storage at the single molecule level

The miniaturization of the current technology of storage media is hindered by fundamental limits of quantum mechanics. A new approach consists in using so-called spin-crossover molecules as the smallest possible storage unit. Similar to normal hard drives, these special molecules can save information via their magnetic state. A research team from Kiel University has now managed to successfully place a new class of spin-crossover molecules onto a surface and to improve the molecule’s storage capacity. The storage density of conventional hard drives could therefore theoretically be increased by more than one hundred fold. The study has been published in the scientific journal Nano Letters.

Over the past few years, the building blocks of storage media have gotten ever smaller. But further miniaturization of the current technology is hindered by...

Im Focus: Successful Mechanical Testing of Nanowires

With innovative experiments, researchers at the Helmholtz-Zentrums Geesthacht and the Technical University Hamburg unravel why tiny metallic structures are extremely strong

Light-weight and simultaneously strong – porous metallic nanomaterials promise interesting applications as, for instance, for future aeroplanes with enhanced...

Im Focus: Virtual Reality for Bacteria

An interdisciplinary group of researchers interfaced individual bacteria with a computer to build a hybrid bio-digital circuit - Study published in Nature Communications

Scientists at the Institute of Science and Technology Austria (IST Austria) have managed to control the behavior of individual bacteria by connecting them to a...

Im Focus: A space-time sensor for light-matter interactions

Physicists in the Laboratory for Attosecond Physics (run jointly by LMU Munich and the Max Planck Institute for Quantum Optics) have developed an attosecond electron microscope that allows them to visualize the dispersion of light in time and space, and observe the motions of electrons in atoms.

The most basic of all physical interactions in nature is that between light and matter. This interaction takes place in attosecond times (i.e. billionths of a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

AKL’18: The opportunities and challenges of digitalization in the laser industry

07.12.2017 | Event News

 
Latest News

Midwife and signpost for photons

11.12.2017 | Physics and Astronomy

How do megacities impact coastal seas? Searching for evidence in Chinese marginal seas

11.12.2017 | Earth Sciences

PhoxTroT: Optical Interconnect Technologies Revolutionized Data Centers and HPC Systems

11.12.2017 | Information Technology

VideoLinks
B2B-VideoLinks
More VideoLinks >>>